| Summary of Disaggregated Amounts that Comprise Research and Development and General and Administrative Expenses |
In addition to the significant expense categories included within consolidated net income (loss) presented on the Company's condensed consolidated statements of operations and comprehensive income (loss), see below for disaggregated amounts that comprise research and development and general and administrative expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
THREE MONTHS ENDED
JUNE 30, |
|
|
SIX MONTHS ENDED
JUNE 30, |
|
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Research and development: |
|
|
|
|
|
|
|
|
|
|
|
|
Clinical development |
|
$ |
3,051 |
|
|
$ |
921 |
|
|
$ |
4,296 |
|
|
$ |
1,747 |
|
Employee-related |
|
|
2,957 |
|
|
|
3,411 |
|
|
|
5,109 |
|
|
|
6,139 |
|
Facility and equipment costs |
|
|
490 |
|
|
|
379 |
|
|
|
868 |
|
|
|
756 |
|
Pre-clinical research |
|
|
127 |
|
|
|
149 |
|
|
|
244 |
|
|
|
201 |
|
Other research and development segment expenses |
|
|
366 |
|
|
|
119 |
|
|
|
490 |
|
|
|
238 |
|
Total research and development |
|
|
6,991 |
|
|
|
4,979 |
|
|
|
11,007 |
|
|
|
9,081 |
|
General and administrative: |
|
|
|
|
|
|
|
|
|
|
|
|
Employee-related |
|
|
1,945 |
|
|
|
1,867 |
|
|
|
3,661 |
|
|
|
3,506 |
|
Professional and consulting fees |
|
|
1,436 |
|
|
|
1,208 |
|
|
|
3,238 |
|
|
|
2,876 |
|
Commercial readiness |
|
|
343 |
|
|
|
— |
|
|
|
475 |
|
|
|
— |
|
Other general and administrative segment expenses (1) |
|
|
462 |
|
|
|
517 |
|
|
|
926 |
|
|
|
1,010 |
|
Total general and administrative |
|
|
4,186 |
|
|
|
3,592 |
|
|
|
8,300 |
|
|
|
7,392 |
|
Total operating expenses |
|
|
11,177 |
|
|
|
8,571 |
|
|
|
19,307 |
|
|
|
16,473 |
|
Loss from operations |
|
|
(11,177 |
) |
|
|
(8,571 |
) |
|
|
(19,307 |
) |
|
|
(16,473 |
) |
Interest income |
|
|
926 |
|
|
|
240 |
|
|
|
1,860 |
|
|
|
560 |
|
Interest expense |
|
|
(236 |
) |
|
|
(567 |
) |
|
|
(542 |
) |
|
|
(1,213 |
) |
Change in fair value of warrant liability |
|
|
5,691 |
|
|
|
(13,339 |
) |
|
|
20,572 |
|
|
|
(13,332 |
) |
Net income (loss) |
|
$ |
(4,796 |
) |
|
$ |
(22,237 |
) |
|
$ |
2,583 |
|
|
$ |
(30,458 |
) |
|